Ocular Pharmacology and Therapeutics Conference

眼部药理学和治疗会议

• 批准号: 8837851
• 负责人: W Daniel Stamer
• 金额: $ 2.5万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-12-01 至 2015-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8837851
• 关键词: Academia; Address; Area; Award; Basic Science; Blood flow; Caring; Clinical Research; Collaborations; Creativeness; Devices; Diagnosis; Disease; Doctor of Philosophy; Drug Delivery Systems; Environment; Ethnic group; Evaluation; Eye; Eye diseases; Feedback; Fellowship; Fostering; Funding; Future; Gene Mutation; Glaucoma; Goals; Immunology; Individual; Industry; International; Ischemia; Knowledge; Lead; Mind; Modification; Nature; Ophthalmologist; Participant; Pharmaceutical Preparations; Pharmacologic Substance; Pharmacology; Recording of previous events; Recruitment Activity; Research; Research Personnel; Resources; Retinal; Scientist; South Carolina; Students; Technology; Therapeutic; Time; Translational Research; Translations; Travel; Underrepresented Minority; Universities; Vision; Vision research; Woman; Work; age effect; base; career; career development; direct application; drug development; drug discovery; educational atmosphere; interest; lectures; meetings; new technology; next generation; novel; novel strategies; novel therapeutic intervention; novel therapeutics; ocular surface; posters; pre-doctoral; processing speed; professor; programs; public health relevance; response; social; symposium; technology development; unpublished works

 DESCRIPTION (provided by applicant): This proposal seeks support for the XII Biennial Conference of the Association for Ocular Pharmacology and Therapeutics (AOPT) to be held February 26th - March 1st, 2015 in Charleston, SC. As with the previous eleven meetings, the goal of AOPT 2015 is to bring together basic scientists, clinicians, students and fellows for presentations and in-depth discussions on new approaches for treating sight-threatening eye diseases. Selection of each of the scientific sessions was based on identification of those ocular fields making important advances that will lead to new therapeutics. We have recruited experts and leaders in these respective areas to chair and program these scientific sessions. In addition to a keynote lecture by Professor Palczewski, we identified ten exciting topics for inclusion in our conference. Additionally, a specific goal of the conference is to increase student and junior investigator participation with travel awards and a featured 11th platform session for young scientists. AOPT has an established history for promoting diversity, and the speakers that are selected represent a diverse group of scientists including women and underrepresented individuals. The Specific Aims of the XII Association for Ocular Pharmacology and Therapeutics Conference are: 1. to enhance the emerging careers of 20 young investigators (including women and underrepresented minorities) in ocular therapeutics by providing travel awards. 2. To provide a forum for dissemination of the most recent advances in the state of knowledge on novel therapeutic approaches to ocular disorders and disease. 3. To create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists and generate the opportunity for vision scientists of all ethnic groups and social backgrounds to meet and establish research collaborations. 4. To bring together scientists working in academia and industry with the goal of expediting the delivery of novel therapeutics to those suffering from ocular diseases or disorders. We anticipate that this meeting will provide useful information on recent advances in ocular diseases and will serve as an important resource for those involved in the translation of these findings into suitable therapeutics. This conference will also provide new opportunities, avenues for new discovery, and a forum to develop potential collaborations among the attendees. The requested funds will support the travel, accommodation and registration of 10 students (pre- and postdoctoral) and 10 junior investigators who otherwise would not have the resources to attend this focused meeting.

 描述（由申请人提供）：本提案寻求对将于 2015 年 2 月 26 日至 3 月 1 日在南卡罗来纳州查尔斯顿举行的眼部药理学和治疗协会第十二届双年度会议 (AOPT) 的支持。与之前的十一次会议一样，AOPT 2015 的目标是将基础科学家、临床医生、学生和研究员聚集在一起，就治疗威胁视力的眼部疾病的新方法进行演讲和深入讨论。每场科学会议的选择都是基于对那些取得重要进展、将带来新疗法的眼部领域的识别。我们招募了这些领域的专家和领导者来主持和安排这些科学会议。除了 Palczewski 教授的主题演讲之外，我们还确定了十个令人兴奋的主题纳入我们的会议。此外，会议的一个具体目标是通过旅行奖励和针对年轻科学家的第 11 届特色平台会议来增加学生和初级研究员的参与。 AOPT 在促进多样性方面有着悠久的历史，所选的演讲者代表了多元化的科学家群体，包括女性和代表性不足的个人。第十二届眼部药理学和治疗学协会会议的具体目标是： 1. 通过提供旅行奖励，促进 20 名年轻研究人员（包括女性和代表性不足的少数族裔）在眼部治疗领域的新兴职业生涯。 2. 提供一个论坛，传播眼部疾病和新治疗方法的最新知识进展。 3. 创造一个有利于基础科学家和临床科学家之间交流新思想的环境，并为所有种族和社会背景的视觉科学家创造见面和建立研究合作的机会。 4. 将学术界和工业界的科学家聚集在一起，目标是加快为眼部疾病或病症患者提供新的治疗方法。我们预计这次会议将提供有关眼部疾病最新进展的有用信息，并将为那些参与将这些发现转化为合适疗法的人员提供重要资源。本次大会还将推出新 机会、新发现的途径以及在与会者之间发展潜在合作的论坛。所申请的资金将用于支持 10 名学生（博士前和博士后）和 10 名初级研究人员的旅行、住宿和注册，否则他们将没有资源参加这次重点会议。